Delivery Order SPE2DP20D0002-SPE2DP22F2117

Award Date 1/18/22
Potential Completion Date 1/25/22
Potential Value $440K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Parsippany, NJ 07054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
<p>The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded Teva Pharmaceuticals USA, Inc. a $293,647.86 firm fixed price delivery order contract to provide Adenovirus Type 4 from January 18, 2022 through January 25, 2022. The place of performance will be Teva Pharmaceuticals' facility located in Parsippany, New Jersey. No subcontractors were identified.</p>
<p>The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded Teva Pharmaceuticals USA, Inc. a $440,471.79 firm fixed price delivery order contract to provide adenovirus type 4 from April 19, 2022 through April 26, 2022. The place of performance for this contract is Parsippany, New Jersey. No subcontractors were identified.</p>
<p>The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded Teva Pharmaceuticals USA, Inc. a $763,484.40 firm fixed price delivery order contract to provide Adenovirus Type 4. The prime contractor, Teva Pharmaceuticals USA, Inc., will perform all work at their location in Parsippany, New Jersey, with work beginning on July 18, 2023 and concluding on July 25, 2023.</p>
<p>The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded Teva Pharmaceuticals USA, Inc. a $610,787.52 firm fixed price delivery order contract to provide adenovirus type 4 from April 19, 2023 through April 25, 2023. The place of performance will be Teva Pharmaceuticals' facility located in Parsippany, New Jersey. No subcontractors were identified.</p>
<p>The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded Teva Pharmaceuticals USA, Inc. a $440,471.79 firm fixed price delivery order contract to provide adenovirus type 4 from April 19, 2022 through April 26, 2022. The place of performance for this contract is Parsippany, New Jersey. No subcontractors were identified.</p>
<p>The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $423,530.64 firm fixed price delivery order contract to provide Adenovirus Type 4. The prime contractor, Teva Pharmaceuticals USA, Inc., is located in Parsippany, New Jersey and will perform the work at that location from December 7, 2021 through December 14, 2021.</p>
<p>The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded Teva Pharmaceuticals USA, Inc. a $610,787.52 firm fixed price delivery order contract to provide Adenovirus Type 4. The prime contractor, Teva Pharmaceuticals USA, Inc., will perform all work at their location in Parsippany, New Jersey, with performance beginning on June 20, 2023 and concluding on June 27, 2023.</p>
<p>The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $282,353.76 firm fixed price delivery order contract to provide Adenovirus Type 4. The prime contractor, Teva Pharmaceuticals USA, Inc., is located in Parsippany, New Jersey and will perform the work at that location from December 7, 2021 through December 14, 2021.</p>
The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded Teva Pharmaceuticals USA, Inc. a $587,295.72 firm fixed price delivery order contract to provide adenovirus type 4 from April 19, 2022 through April 26, 2022. The place of performance for this contract is Parsippany, New Jersey. Teva Pharmaceuticals USA, Inc. will serve as the prime contractor to supply adenovirus type 4 to the Defense Logistics Agency Troop Support Medical. No applicable subcontractors were identified.
<p>The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded Teva Pharmaceuticals USA, Inc. a $763,484.40 firm fixed price delivery order contract to provide adenovirus type 4 with a period of performance starting on May 17, 2023 through May 23, 2023. Teva Pharmaceuticals USA, Inc. will perform the contract from its location in Parsippany, New Jersey. No subcontractors were identified.</p>
  • SPE2DP20D0002
    Indefinite Delivery Contract
  • SPE2DP20D0002-SPE2DP22F2117
    Delivery Order

The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded Teva Pharmaceuticals USA, Inc. a $440,471.79 firm fixed price delivery order contract to provide adenovirus type 4. The prime contractor, Teva Pharmaceuticals USA, Inc., will perform the work in Parsippany, New Jersey from January 18, 2022 through January 25, 2022.

Generated 11/27/23, 5:48 PM